Jeena Sikho Lifecare Limited has submitted to the Exchange, Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jeena Sikho Lifecare Limited has reported strong audited financial results for FY2026 ending March 31, 2026. Standalone revenue from operations grew 70.8% to Rs. 80,134.64 lakhs from Rs. 46,907.19 lakhs in FY2025. Profit after tax (PAT) more than doubled to Rs. 22,217.57 lakhs from Rs. 7,994.33 lakhs, representing a 178% increase. Basic EPS improved to Rs. 17.87 from Rs. 6.43. The company operates in Ayurvedic products/medicines and healthcare services segments, with both contributing equally to revenues. The Board recommended a final dividend of Rs. 4.50 per equity share (face value Rs. 2). Statutory auditors Walker Chandiok & Co LLP issued unmodified opinions on both standalone and consolidated financial results. Net cash from operating activities stood at Rs. 26,199.25 lakhs, significantly up from Rs. 8,450.31 lakhs.
The company delivered exceptional growth with revenue and PAT both more than doubling year-on-year, indicating strong business momentum. The clean audit opinion and robust operating cash flows are positive signals for shareholders. The dividend payout demonstrates management confidence in future cash generation.